Literature DB >> 22273852

[Liver transplantation for hilar cholangiocarcinoma].

F Rauchfuss1, F Utess, S Schüle, Y Dittmar, H Scheuerlein, U Settmacher.   

Abstract

Local non-resectable, hilar cholangiocarcinoma can be cured by performing a liver transplantation. The initially poor results after transplantation have significantly improved since neoadjuvant therapy protocols have been established. Therefore, hilar cholangiocarcinoma is now an accepted indication for liver transplantation in selected patients. This article summarizes the current state, recommendations and results of liver transplantation for these patients.

Entities:  

Mesh:

Year:  2012        PMID: 22273852     DOI: 10.1007/s00104-011-2178-5

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  54 in total

Review 1.  Liver transplantation for cholangiocarcinoma.

Authors:  Charles B Rosen; Julie K Heimbach; Gregory J Gores
Journal:  Transpl Int       Date:  2010-05-20       Impact factor: 3.782

2.  Down-regulated expression of HSP70 in correlation with clinicopathology of cholangiocarcinoma.

Authors:  Sirintip Boonjaraspinyo; Thidarut Boonmars; Sasithorn Kaewkes; Porntip Laummaunwai; Somchai Pinlaor; Watchalin Loilome; Puangrat Yongvanit; Zhiliang Wu; Anucha Puapairoj; Vajarabhongsa Bhudhisawasdi
Journal:  Pathol Oncol Res       Date:  2011-07-13       Impact factor: 3.201

Review 3.  Preoperative portal vein embolization: indications and technical considerations.

Authors:  Thierry de Baere; Alban Denys; David C Madoff
Journal:  Tech Vasc Interv Radiol       Date:  2007-03

Review 4.  Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature.

Authors:  M Shimoda; D G Farmer; S D Colquhoun; M Rosove; R M Ghobrial; H Yersiz; P Chen; R W Busuttil
Journal:  Liver Transpl       Date:  2001-12       Impact factor: 5.799

5.  Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies.

Authors:  T E Starzl; S Todo; A Tzakis; L Podesta; L Mieles; A Demetris; L Teperman; R Selby; W Stevenson; A Stieber
Journal:  Ann Surg       Date:  1989-09       Impact factor: 12.969

6.  Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI.

Authors:  Y Zhang; M Uchida; T Abe; H Nishimura; N Hayabuchi; Y Nakashima
Journal:  J Comput Assist Tomogr       Date:  1999 Sep-Oct       Impact factor: 1.826

7.  Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.

Authors:  U Broomé; R Löfberg; B Veress; L S Eriksson
Journal:  Hepatology       Date:  1995-11       Impact factor: 17.425

8.  Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.

Authors:  Takashi Kato; Eriko Tsukamoto; Yuji Kuge; Chietsugu Katoh; Toshikazu Nambu; Aichiro Nobuta; Satoshi Kondo; Masahiro Asaka; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-06-01       Impact factor: 9.236

Review 9.  Magnetic resonance imaging of cholangiocarcinoma.

Authors:  Riccardo Manfredi; Brunella Barbaro; Gabriele Masselli; Amorino Vecchioli; Pasquale Marano
Journal:  Semin Liver Dis       Date:  2004-05       Impact factor: 6.115

10.  Liver transplantation for unresectable perihilar cholangiocarcinoma.

Authors:  Julie K Heimbach; Gregory J Gores; Michael G Haddock; Steven R Alberts; Scott L Nyberg; Michael B Ishitani; Charles B Rosen
Journal:  Semin Liver Dis       Date:  2004-05       Impact factor: 6.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.